Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor UI/metadata update and does not affect the study content.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check23 days agoChange DetectedRemoved the government funding lapse notice about NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedNo significant changes detected in core study information between the two screenshots; any differences seem limited to formatting or minor layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedCore page content updated to reflect current operating status and a new version (v3.2.0); previous version (v3.0.2) is removed.SummaryDifference3%

- Check68 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.